Francisco Partners to exit Aesynt

Francisco Partners said Thursday it has agreed to sell Aesynt Inc. to Omnicell Inc. for $275 million. Cranberry Township, Pennsylvania-based Aesynt provides a medication management portfolio that aims to reduce cost and improve patient safety. Francisco Partners acquired Aesynt in October 2013.

DealsNorth AmericaUSBriefs